Cannara Biotech Stock Filter Stocks by Fundamentals
LOVFF Stock | USD 0.59 0.08 15.69% |
Cannara Biotech fundamentals help investors to digest information that contributes to Cannara Biotech's financial success or failures. It also enables traders to predict the movement of Cannara OTC Stock. The fundamental analysis module provides a way to measure Cannara Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cannara Biotech otc stock.
Cannara |
Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
All Next | Launch Module |
Cannara Fundamentals
Return On Equity | 0.0434 | |||
Return On Asset | 0.0327 | |||
Profit Margin | 0.07 % | |||
Operating Margin | 0.15 % | |||
Current Valuation | 94.03 M | |||
Shares Outstanding | 877.48 M | |||
Shares Owned By Insiders | 47.54 % | |||
Price To Earning | 85.00 X | |||
Price To Book | 1.37 X | |||
Price To Sales | 1.81 X | |||
Revenue | 35.84 M | |||
Gross Profit | 17.33 M | |||
EBITDA | 8.14 M | |||
Net Income | 2.31 M | |||
Cash And Equivalents | 3.88 M | |||
Total Debt | 46.19 M | |||
Debt To Equity | 0.49 % | |||
Current Ratio | 2.13 X | |||
Book Value Per Share | 0.08 X | |||
Cash Flow From Operations | (6.08 M) | |||
Earnings Per Share | 0.15 X | |||
Beta | 1.52 | |||
Market Capitalization | 63.27 M | |||
Total Asset | 125.62 M | |||
Z Score | 0.6 | |||
Net Asset | 125.62 M |
About Cannara Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cannara Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cannara Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cannara Biotech based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Cannara OTC Stock
Cannara Biotech financial ratios help investors to determine whether Cannara OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cannara with respect to the benefits of owning Cannara Biotech security.